HilleVax, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 123.57 million compared to USD 159.81 million a year ago. Basic loss per share from continuing operations was USD 3.04 compared to USD 5.89 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.06 USD | -0.28% |
|
-2.77% | -12.40% |
May. 24 | Recursion Names HilleVax CEO Robert Hershberg as New Board Chair | MT |
May. 22 | Hillevax Insider Sold Shares Worth $266,291, According to a Recent SEC Filing | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.40% | 668M | |
+18.97% | 45.34B | |
+41.98% | 40.42B | |
-10.06% | 37.92B | |
+31.15% | 31.75B | |
-7.79% | 27.71B | |
+13.32% | 26.52B | |
+43.05% | 13.96B | |
+31.28% | 12.44B | |
-7.41% | 11.26B |
- Stock Market
- Equities
- HLVX Stock
- News HilleVax, Inc.
- HilleVax, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023